losartan and Kawasaki Disease studies

Losartan: An antagonist of ANGIOTENSIN TYPE 1 RECEPTOR with antihypertensive activity due to the reduced pressor effect of ANGIOTENSIN II.
losartan : A biphenylyltetrazole where a 1,1'-biphenyl group is attached at the 5-position and has an additional trisubstituted imidazol-1-ylmethyl group at the 4'-position

Research Excerpts

Excerpt	Relevance	Reference
" Besides its antihypertensive effects, losartan can modulate inflammation in cardiovascular disease."	7.85	Losartan attenuates the coronary perivasculitis through its local and systemic anti-inflammatory properties in a murine model of Kawasaki disease. ( Aiba, Y; Hayashi, K; Kato, M; Koga, Y; Matsuda, S; Mochizuki, H; Nakamura, H; Niimura, F; Sekine, K; Suganuma, E; Takahashi, O; Ukawa, T, 2017)
" Besides its antihypertensive effects, losartan can modulate inflammation in cardiovascular disease."	3.85	Losartan attenuates the coronary perivasculitis through its local and systemic anti-inflammatory properties in a murine model of Kawasaki disease. ( Aiba, Y; Hayashi, K; Kato, M; Koga, Y; Matsuda, S; Mochizuki, H; Nakamura, H; Niimura, F; Sekine, K; Suganuma, E; Takahashi, O; Ukawa, T, 2017)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

losartan and Kawasaki Disease

Research Excerpts

Research

Studies (1)

Authors

Other Studies

Authors	Studies
Suganuma, E	1
Niimura, F	1
Matsuda, S	1
Ukawa, T	1
Nakamura, H	1
Sekine, K	1
Kato, M	1
Aiba, Y	1
Koga, Y	1
Hayashi, K	1
Takahashi, O	1
Mochizuki, H	1